Remote monitoring for patients with Chronic Obstructive Pulmonary Disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the Bora Care remote monitoring solution in detecting early acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD). It aims to validate the use of telemonitoring tools to track various parameters such as cardio-respiratory metrics, environmental factors, and symptom questionnaires. By identifying exacerbations early, the study seeks to improve patient outcomes and reduce healthcare costs associated with COPD management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient with COPD defined according to the SPLF recommendations, whose level of lung function in a stable state is known (measurement less than 12 months old)
* Patient with at least one of the following criteria :

  * Hospitalized for a COPD exacerbation at the time of enrolment in the study, and having had at least one other exacerbation in the last 12 months
  * Followed-up and part of the active file of the site, having had at least 2 exacerbations during the last 12 months, including one with hospitalization
  * COPD patient with at least 2 exacerbations in the last 12 months, including one with hospitalization
* Patient having given written informed consent to participate in the study
* Patient affiliated to the French social security system

Exclusion Criteria

* Vulnerable patient (minor, protected adult, prisoner)
* Patient unable to use the BoraBand tool and without access to a caregiver
* Presence of a comorbidity considered unstable or very severe by the investigator
* Patient already participating in another interventional research study

Where it's running

• Pneumology Department - Hôpital Cochin
  Paris, France Recruiting

Study contacts

• Principal investigator: Nicolas ROCHE, MD, PhD — Assistance Publique - Hôpitaux de Paris
• Study coordinator: Nicolas ROCHE, MD, PhD
• Email: nicolas.roche@aphp.fr
• Phone: 01 58 41 21 53

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Flutter therapy added to chest physiotherapy after CABG in COPD patients

  This study tests whether adding Flutter therapy to standard chest physiotherapy helps post-CABG patients with mild-to-moderate COPD improve breathing more than chest physiotherapy alone.

  Recruiting Foundation University Islamabad · Rawalpindi · NCT07875049

• TPB-based cadence exercise and breathing training for COPD patients

  A TPB-based program tests whether breathing training, cadence-guided walking, or both can improve lung function, exercise capacity, and quality of life in adults with COPD.

  Recruiting Fu Jen Catholic University Hospital · New Taipei City, New Taipei City and 1 other locations · NCT07860008

• See how dynamic chest X-rays relate to COPD patterns and progression risk

  This study looks at existing dynamic chest radiography data to see if new imaging measurements can identify COPD patterns, gauge severity, and predict who may experience faster progression.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07762573

• Personalized mobile app warnings to reduce COPD flares

  A personalized mobile app tests whether providing temperature-related risk warnings and protective tips, in addition to usual COPD care, can lower COPD flare-ups over 12 months.

  Recruiting at 4 sites Centers for Disease Control and Prevention, China · Beijing and 3 other locations · NCT07656142

• CLEAR model to predict when people with severe COPD can be taken off ventilatory support

  This project will see if the CLEAR model can predict which adults with severe COPD on invasive or non‑invasive ventilation can be safely taken off ventilatory support.

  Recruiting Assiut University · Asyut, Assuit Egypt · NCT07579052

• Long-term safety of Tozorakimab in COPD patients with prior exacerbations

  This study tests two long-term dosing regimens of tozorakimab in people with COPD who have a history of flare-ups and who completed earlier studies.

  Recruiting at 5 sites Phase 3 AstraZeneca · Aix-en-Provence and 12 other locations · NCT07566195

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.